Infant Formula Supplementation With Long‐chain Polyunsaturated Fatty Acids Has No Effect on Bayley Developmental Scores at 18 Months of Age—IPD Meta‐analysis of 4 Large Clinical Trials
- 1 January 2010
- journal article
- research article
- Published by Wiley in Journal of Pediatric Gastroenterology and Nutrition
- Vol. 50 (1) , 79-84
- https://doi.org/10.1097/mpg.0b013e3181acae7d
Abstract
Objectives: To find out whether supplementation of formula milk by long-chain polyunsaturated fatty acids (LCPUFA) affects neurodevelopment at 18 months of age in term or preterm infants by an individual patient data (IPD) meta-analysis. Materials and Methods: Data of 870 children from 4 large randomised clinical trials for formula milk with and without LCPUFAs allowed for assessing the effect of LCPUFA with adjustment For potential confounders and extensive subgroup analysis on prematurity, LCPUFA Source, and dosage. Any additional clinical trials examining the effect of LCPUFA supplementation on Bayley Scales of Infant Development at 18 months were regarded as relevant. Two relevant studies were identified by MEDLINE, but were not available to us. An IPD meta-analysis was performed with Subgroup analyses by preterm delivery, very low birth weight (<1500g), trials with higher amounts of docosahexaenoic acid (DHA) and arachidonic acid (AA), and Specific Sources of LCPUFA. The sample size of 870 children was Sufficient to detect clinically relevant differences in Bayley Scales even in subgroups. Results: There were no significant differences in mental or psychomotor developmental indexes between LCPUFA-supplemented and control groups for all children or in Subgroups. This was confirmed with adjustment for the possible confounders: sex, gestational age, birth weight, maternal age, and maternal smoking. The adjusted mean differences in mental developmental index and psychomotor developmental index for all of the children were -0.8 (95% confidence interval -2.8 to 1.2) and -1.0 (-2.7 to 0.7), respectively. Conclusions: These data based on considerable sample size Provide evidence that LCPUFA supplementation of infant formula does not have a clinically meaningful effect on the neurodevelopment as,assessed by Bayley scores at 18 months. Inclusion of all relevant data should not have led to differing conclusions except, possibly, for very-low-birth-weight infants.Keywords
This publication has 34 references indexed in Scilit:
- Longchain polyunsaturated fatty acid supplementation in preterm infantsPublished by Wiley ,2008
- Session 6: Infant nutrition: future research developments in Europe EARNEST, the early nutrition programming project: EARly Nutrition programming – long-term Efficacy and Safety Trials and integrated epidemiological, genetic, animal, consumer and economic researchProceedings of the Nutrition Society, 2007
- Cognitive assessment of children at age 2½ years after maternal fish oil supplementation in pregnancy: a randomised controlled trialArchives of Disease in Childhood: Fetal & Neonatal, 2006
- Long-Chain Polyunsaturated Fatty Acids in Early Life: Effects on Multiple Health OutcomesPublished by S. Karger AG ,2006
- LC‐PUFA content in human milk: Is it always optimal?Acta Paediatrica, 2005
- Growth and development of preterm infants fed infant formulas containing docosahexaenoic acid and arachidonic acidThe Journal of Pediatrics, 2005
- Randomized, double-blind trial of long-chain polyunsaturated fatty acid supplementation with fish oil and borage oil in preterm infantsThe Journal of Pediatrics, 2004
- Plasma long-chain polyunsaturated fatty acids and neurodevelopment through the first 12 months of life in phenylketonuriaDevelopmental Medicine and Child Neurology, 2003
- Dietary supplementation of long‐chain polyunsaturated fatty acids in preterm infants: effects on cerebral maturationActa Paediatrica, 2002
- A randomized controlled trial of early dietary supply of long‐chain polyunsaturated fatty acids and mental development in term infantsDevelopmental Medicine and Child Neurology, 2000